Phase II Study of Paclitaxel Plus Gemcitabine in Refractory Germ Cell Tumors (E9897): A Trial of the Eastern Cooperative Oncology Group PURPOSE: To characterize the clinical and biologic features of ...
Ready to start planning your care? Call us at 800-525-2225 to make an appointment.
Gender disparities in the National Institutes of Health funding for gastrointestinal oncology. Evaluating novel therapies and circulating tumor DNA (ctDNA) as a marker of response in curatively ...
A 31-year-old man presented to his urologist with a left hemiscrotal mass. Following left radical orchiectomy, pathology demonstrated a mixed germ-cell neoplasm with angiolymphatic invasion. Although ...
Forty-four samples from 25 cases of retroperitoneal sarcoma initially diagnosed as malignant fibrous histiocytoma were histologically reviewed. Immunohistochemistry for mdm2 and cdk4 was performed on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results